Press release
Why is the Electrophysiology Devices Market Reach US$22.63 Billion by 2033 as a 10.7% CAGR Accelerates Mapping and Ablation Innovation?
Electrophysiology Devices Market Size
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for Quick Response):
https://www.datamintelligence.com/download-sample/electrophysiology-devices-market?mg
2026 Official Developments in Electrophysiology Devices, Mapping Systems and Integrated Arrhythmia Care Platforms
✅ March 2026: Medtronic announced that its Sphere-9 catheter for the Affera Mapping and Ablation System became eligible for insurance coverage in Japan, supporting clinical use for electrophysiological mapping and treatment of specified atrial fibrillation and atrial flutter indications.
✅ April 2026: Medtronic announced new clinical milestones for its Affera platform and Sphere-9 and Sphere-360 catheters, including continued development in atrial fibrillation and ventricular tachycardia applications.
✅ April 2026: Boston Scientific highlighted its FARAPULSE Pulsed Field Ablation Platform and integrated mapping capabilities at Heart Rhythm 2026, including clinical data from AF and next-generation PFA programs.
✅ April 2026: Abbott showcased advances in mapping, ablation and pulsed-field ablation technologies at EHRA 2026, including its integrated EP workflow and evolving PFA portfolio.
✅ June 2026: Medtronic announced strategic investments in Beluga Medical and CardioACC to support expansion of its cardiac ablation portfolio, with plans to integrate intracardiac echocardiography capabilities into the Affera ecosystem.
Ready to Expand in the Electrophysiology Devices Market? Find the Right Partners Today:
https://www.datamintelligence.com/partner-identification-enquiry/electrophysiology-devices-market?mg
Key Companies in the Electrophysiology Devices Market
Key companies identified by DataM Intelligence include Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic, Boston Scientific Corporation, Siemens Healthineers AG, GE HealthCare, Philips Healthcare, Acutus Medical, Stereotaxis and MicroPort Scientific Corporation, among others.
Medtronic offers an integrated cardiac mapping and ablation portfolio that includes the Affera Mapping and Ablation System and Sphere-9 catheter. The company describes Affera as an integrated platform combining high-definition mapping with dual-energy ablation capabilities.
Boston Scientific has expanded its electrophysiology portfolio around the FARAPULSE PFA Platform and OPAL HDx Mapping System. Its FARAVIEW software integrates mapping with PFA workflows and provides visualization of catheter position, contact and estimated energy-field coverage.
Abbott continues to develop its electrophysiology portfolio around mapping, ablation and pulsed-field technologies. Its 2026 EHRA program highlighted integrated workflow solutions and evolving PFA technologies.
Biosense Webster, part of Johnson & Johnson MedTech, remains a major participant in cardiac mapping and ablation. Its CARTO ecosystem is among the established platforms supporting three-dimensional electrophysiology procedures. DataM Intelligence lists Biosense Webster among the major global players.
Regional Market Readiness
The United States remains a major electrophysiology market because of advanced cardiac-care infrastructure, high procedure volumes, specialized EP centers and strong adoption of innovative medical technologies. The region also has an established regulatory and reimbursement framework for advanced electrophysiology devices.
Japan combines an aging population with sophisticated cardiovascular care infrastructure. The 2026 insurance coverage milestone for Medtronic's Sphere-9 catheter demonstrates how reimbursement decisions can influence the commercialization pathway for advanced EP technologies.
Germany offers a strong environment for electrophysiology technologies because of specialist cardiac centers, medical-engineering capabilities and established healthcare quality requirements. Reimbursement and evidence generation remain important considerations for technology adoption.
South Korea is developing advanced hospital-based electrophysiology capabilities supported by sophisticated medical technology, electronics and device-manufacturing infrastructure. The country provides opportunities for advanced EP systems, mapping technologies and ablation platforms.
DataM Intelligence reports that North America accounted for 40.3% of the global electrophysiology market in 2024, supported by healthcare infrastructure, technological investment and demand for advanced arrhythmia treatment.
Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=electrophysiology-devices-market?mg
Electrophysiology Devices Market Segmentation
According to DataM Intelligence, the electrophysiology devices market is segmented by product type, indication, end user and region.
By product type, the market includes EP ablation catheters, EP diagnostic catheters, EP laboratory devices, access devices and others.
By indication, the market covers atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia, ventricular tachycardia and other arrhythmias.
By end user, the market includes hospitals, ambulatory surgical centers, specialized clinics and diagnostic centers.
DataM Intelligence identifies EP ablation catheters as a leading product segment, supported by demand for catheter-based treatment of atrial fibrillation and other arrhythmias.
Pulsed-Field Ablation Is Reshaping EP Procedure Strategy
One of the most important technology shifts in the electrophysiology devices market is the growing focus on pulsed-field ablation.
Unlike conventional thermal ablation approaches, PFA uses electrical fields to create controlled tissue effects. Its development has encouraged companies to compete around catheter design, energy delivery, mapping integration and procedural workflow.
Boston Scientific's FARAVIEW technology illustrates this convergence. The system integrates with the OPAL HDx Mapping System and provides dynamic visualization of catheter position, contact and estimated PFA field coverage.
Medtronic is pursuing another integrated approach through Affera. The Sphere-9 catheter combines high-density mapping with dual-energy pulsed-field and radiofrequency ablation capabilities.
This indicates that competition is moving beyond individual catheters toward complete EP workflow ecosystems.
Mapping Precision and Digital Integration Become Competitive Factors
Modern electrophysiology procedures increasingly depend on accurate visualization of cardiac electrical activity.
Three-dimensional mapping systems can help physicians understand electrical pathways and guide ablation. Software integration can further connect mapping, imaging, procedural planning and treatment validation.
DataM Intelligence identifies technological advancement as an important market driver, with improvements in mapping systems, catheter design, AI-enabled data analysis and real-time monitoring supporting the evolution of EP care.
The direction of development suggests that future EP laboratories may increasingly evaluate systems based on the efficiency of the overall workflow rather than the performance of an individual device.
Procedure Efficiency Creates New Opportunities
The growing focus on procedure efficiency creates opportunities for companies developing integrated EP devices, cardiac mapping systems and arrhythmia treatment technologies.
Medtronic's Affera platform, for example, is designed to combine mapping and ablation within an integrated system. Its clinical program has also focused on procedural efficiency and expanding applications into ventricular tachycardia.
Boston Scientific is similarly connecting PFA with mapping and workflow software through the FARAPULSE and OPAL HDx ecosystem.
These developments create opportunities across:
• Pulsed-field ablation platforms
• 3D cardiac mapping
• EP diagnostic catheters
• Ablation catheters
• Intracardiac imaging
• EP laboratory upgrades
• Procedural software
• Training and workflow-support services
Training and Reimbursement Remain Critical
Advanced electrophysiology systems require specialized clinical expertise. DataM Intelligence identifies a shortage of skilled professionals as a restraint because complex ablation and mapping procedures require trained specialists.
Reimbursement is another important consideration. The commercial success of an advanced EP technology depends not only on clinical performance but also on whether healthcare systems can support its adoption.
Medtronic's 2026 reimbursement guide, for example, includes updated 2026 Medicare payment information for cardiac electrophysiology procedures and mapping codes.
For manufacturers, this makes clinical evidence, training infrastructure and reimbursement strategy important components of market entry.
Speak to Our Analyst and Get Customization in the Report as per Your Requirements:
https://www.datamintelligence.com/customize/electrophysiology-devices-market?mg
Integrated EP Labs Could Define the Next Growth Phase
The future of the electrophysiology devices market is increasingly connected to integrated cardiac-care workflows.
Mapping, ablation, imaging, software and procedural monitoring are moving toward more connected systems. This can create opportunities for companies that provide complete solutions rather than isolated components.
The increasing adoption of PFA also creates a competitive environment in which catheter manufacturers, mapping-platform developers and imaging companies can form partnerships or expand their portfolios.
For hospitals, the procurement question is increasingly becoming broader: which technology can improve procedural efficiency, support physician workflow and integrate effectively with existing EP infrastructure?
People Also Ask:-
1. What is the electrophysiology devices market?
The electrophysiology devices market includes technologies used to diagnose, map and treat cardiac arrhythmias, including mapping systems, diagnostic catheters and ablation devices.
2. What is the size of the electrophysiology market?
The global electrophysiology market reached US$9.06 billion in 2024 and is projected to reach US$22.63 billion by 2033, growing at a 10.7% CAGR during 2025-2033.
3. What is driving the electrophysiology devices market?
Key drivers include increasing cardiac arrhythmias, minimally invasive treatment demand, 3D mapping, pulsed-field ablation, advanced catheter technologies and digital EP laboratory integration.
4. What is pulsed-field ablation?
Pulsed-field ablation is an energy-based cardiac ablation approach that uses electrical fields for tissue treatment and is becoming an important area of EP technology development.
5. Which companies are leading the electrophysiology devices market?
Major companies identified by DataM Intelligence include Biosense Webster, Abbott, Medtronic, Boston Scientific, Siemens Healthineers, GE HealthCare, Philips Healthcare, Stereotaxis and MicroPort Scientific, among others.
For More Information:
https://www.datamintelligence.com/research-report/electrophysiology-devices-market?mg
Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
About Us
DataM Intelligence is a market research and consulting firm that delivers comprehensive end-to-end business solutions, covering everything from in-depth research to strategic consulting. The company leverages key industry trends, insights, and developments to provide fast, reliable, and actionable solutions tailored to diverse client requirements.
It offers both syndicated and customized research reports supported by a strong and robust methodology. With an extensive database comprising 9000+ reports across 40+ industry domains, DataM Intelligence serves over 200 companies in more than 50 countries, helping organizations access critical business intelligence that drives informed decision-making and sustainable growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Why is the Electrophysiology Devices Market Reach US$22.63 Billion by 2033 as a 10.7% CAGR Accelerates Mapping and Ablation Innovation? here
News-ID: 4603956 • Views: …
More Releases from DataM Intelligence 4 Market Reserach LLP
Why Could the Biodegradable Stents Market Grow at a 5% CAGR as Temporary Scaffol …
The global Biodegradable Stents Market is expected to grow at a CAGR of 5% during 2026-2033, according to DataM Intelligence. The market is developing around the need for temporary vascular support, bioresorbable materials and alternatives to permanent implant structures. Growing cardiovascular disease burden, continued research into polymer-based and metallic biodegradable stents, and demand for minimally invasive vascular interventions are creating opportunities across coronary and peripheral artery applications.
Get a Sample…
Why Could 9.4% CAGR Turn VV-ECLS Into a High-Value Critical-Care Opportunity as …
The Veno-Venous Extracorporeal Life Support Devices Market is gaining strategic relevance as hospitals strengthen their ability to manage severe respiratory failure and expand advanced critical-care capacity. The market is developing at the intersection of VV-ECLS, ECMO devices, critical respiratory support and oxygenator systems, with opportunities emerging across specialized ECMO centers, emergency preparedness, portable systems, training services and regional referral networks.
Get a Sample PDF Brochure of the Report (Use Corporate Email…
Why Is the Ventricular Assist Devices Market Growing at a 10% CAGR as Durable Pu …
The global Ventricular Assist Devices Market is expected to expand at a CAGR of 10% during 2026-2033, driven by the rising burden of heart failure, technological advancements in ventricular support systems and increasing demand for advanced cardiac therapies. The market is evolving toward more durable devices, improved patient management and broader applications including bridge-to-transplant, bridge-to-recovery and destination therapy.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID…
Why Is the Percutaneous Mechanical Circulatory Support Devices Market Booming? U …
The global Percutaneous Mechanical Circulatory Support Devices Market reached US$2.55 billion in 2025 and is expected to reach US$5.20 billion by 2033, growing at a CAGR of 8.7% during 2026-2033. Market growth is being supported by rising demand for rapid hemodynamic stabilization in cardiogenic shock, high-risk PCI and other acute cardiac conditions. Advances in minimally invasive circulatory support technologies, expanding cath-lab capabilities, improved device performance and increasing adoption of specialized…
More Releases for Medtronic
O Arm Surgical Imaging System Market Size, Share and Forecast By Key Players-Med …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global O Arm Surgical Imaging System market is anticipated to grow at a compound annual growth rate (CAGR) of 13.57% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 61.7 Billion by 2031.
The O-arm surgical imaging system market is experiencing robust growth driven by the increasing demand for…
Overview of Global Artificial Intelligence in Operating Room Market | LeanTaaS I …
Astute Analytica, a leading provider of market research and analysis, released its highly anticipated Market Analysis Report on the Global Artificial Intelligence in Operating Room Market. This comprehensive report aims to equip businesses with invaluable insights and data, enabling them to make informed decisions and stay one step ahead of the competition.
Access the Comprehensive PDF Market Research Analysis Report Here: https://www.astuteanalytica.com/request-sample/artificial-intelligence-in-operating-room-market
Global Artificial Intelligence (AI) in operating room market was…
Radiofrequency Ablation Devices for Pain Market Insights 2022 - Medtronic, Angio …
MRInsights.biz publishes a Global Radiofrequency Ablation Devices for Pain Market research study that looks at the industry, major market trends, and historical and expected market data. A market overview, as well as definitions and applications, are included in the study. The market is segmented by application, type, and geography in terms of volume and value.
The investigation's findings are presented in the next section of the chapter. Our analysts provide customers…
Abdominal Pads Market Analysis (2019 - 2025)| Johnson & Johnson, Medtronic, Medl …
The global Ammonia Inhalants market report offers fine intelligence that prepares market players to compete well against their toughest competitors on the basis of growth, sales, and other vital factors. The research study lays emphasis on key growth opportunities and market trends apart from critical market dynamics including market drivers and challenges. With the help of this report, interested parties can equip themselves to adapt according to the changes in…
Global Venous Stents Market 2019 - Boston Scientific, Medtronic, Medtronic, Cook …
The global "Venous Stents Market" report delivers a comprehensive and systematic framework of the Venous Stents market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Venous Stents market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on analysis and calculations. The…
Global Diagnostic Catheter Market 2018 - C.R.Bard, Inc., Medtronic PLC, Johnson, …
Accord Market, recently published a detailed market research study focused on the "Diagnostic Catheter Market" across the global, regional and country level. The report provides 360° analysis of "Diagnostic Catheter Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Diagnostic Catheter industry, and estimates the future trend of Diagnostic Catheter market on…
